Ardelyx | ARDX - Net Income

Stock Price
7.15
Daily Change
-0.24 -3.18%
Monthly
28.51%
Yearly
26.01%
Q1 Forecast
7.45

Ardelyx reported $-969K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Ardelyx USD -969K 18.11M Sep/2025
aTyr Pharma USD -25.74M 6.21M Sep/2025
Corcept Therapeutics USD 19.67M 15.48M Sep/2025
Sanofi EUR -801M 3.6B Dec/2025
TG Therapeutics USD 390.9M 362.71M Sep/2025
United Therapeutics USD 338.7M 29.2M Sep/2025